Combination of dasatinib and blinatumomab offers effective treatment for older Ph+ ALL patients

  • Post author:
  • Post category:uncategorized

Older patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) who were not good candidates for the standard treatment of intensive chemotherapy had a median overall survival (OS) of 6.5…

Continue ReadingCombination of dasatinib and blinatumomab offers effective treatment for older Ph+ ALL patients

Empowering communities: Know Diabetes by Heart initiative awards grants to combat cardiovascular disease

  • Post author:
  • Post category:uncategorized

The American Diabetes Association and the American Heart Association have awarded grants to 10 community organizations to help people living with Type 2 diabetes lower their risk for cardiovascular diseases…

Continue ReadingEmpowering communities: Know Diabetes by Heart initiative awards grants to combat cardiovascular disease